Side-by-side comparison of AI visibility scores, market position, and capabilities
Integrated travel and expense management platform for Indian enterprises with corporate cards and policy automation. Bangalore India, raised $45M+.
Happay is an Indian corporate travel and expense management company that provides an integrated platform covering travel booking, corporate cards, expense management, petty cash, and advance management for enterprises in India and Southeast Asia. Founded in 2012 and headquartered in Bangalore, India, Happay has raised more than $45 million from investors including CRED and Sequoia Capital India. The company has built one of the strongest travel and expense platforms for the Indian enterprise market, where local regulatory requirements, domestic travel patterns, and GST compliance create challenges that global expense platforms address poorly.\n\nHappay's platform provides a Visa-powered corporate card with real-time spend controls and automated expense capture, a travel booking engine with Indian domestic and international content, and an expense management system with GST input tax credit automation — a critical compliance requirement for Indian businesses. The platform handles the full expense lifecycle from advance disbursement through reconciliation and ERP posting, covering the workflows of both field sales teams and corporate travelers in the Indian context.\n\nHappay competes with global players like SAP Concur and local alternatives including EnKash and Zaggle in the Indian corporate spend management market. The company's deep understanding of Indian compliance requirements, its integration with Indian accounting systems, and its local support operations have made it the preferred choice for large Indian enterprises across sectors including FMCG, BFSI, manufacturing, and technology. Happay's acquisition by CRED, India's leading fintech platform for creditworthy users, has provided access to CRED's distribution and financial services infrastructure.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.